INSIGHTS ON LIQUID DOSE MANUFACTURING

• 5 Key Questions On Implementing Pharma 4.0 Solutions For Fill-Finish

  Pharma 4.0™ leverages IoT, AI, and automation to enhance drug quality. Evaluate your fill-finish line readiness by considering five key questions on modularity, high-risk process automation, and data integration.

• CDMO Checklist To Choose The Right Aseptic Isolator

  Selecting the right isolator for aseptic filling requires more than comparing features. Discover essential questions to ask and make informed decisions that align with your process and operational goals.

• Visual Inspection Equipment To Deliver The Highest Product Integrity

  Gain insight into an advanced inspection solution for pharmaceuticals that ensures drug integrity and reduces costs with flexible technologies, from lab development to high-volume production.

• Engineering Challenges Of Designing Pharmaceutical Isolators

  Designing pharmaceutical isolators requires navigating complex engineering hurdles, from ensuring chemical compatibility to optimizing airflow and pressure. Explore the critical considerations that guarantee drug manufacturing safety and efficiency.

• Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality

  5/12/2026

  Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.

• Filling Syringes With Spray-Dried Powders - The How, The Why And The Benefits

  11/3/2025

  Discover how filling spray-dried powders directly into syringes improves stability, minimizes cold chain reliance, and accelerates administration speeds for critical therapies.

• Navigating The New USP Chapter <382> For Elastomeric Closures

  6/24/2025

  Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.

• Commercially Proven Sterile Fill/Finish With Capacity And Global Backing

  1/27/2026

  Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

• Rethinking Fill-Finish To Reduce API Loss In Early Development

  6/15/2026

  Early-stage drug programs can preserve constrained API supplies by replacing large-scale manufacturing defaults with deliberate, right-sized fill-finish designs that minimize avoidable process waste.